University of Vermont

The University of Vermont Cancer Center


Hematologic Malignancy Cancer Clinical Trials

The University of Vermont Cancer Center has many trials specifically focused on hematologic malignancy cancer research.

Status: Active - Recruiting
Study Title:
COG AAML08B1 - Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
Purpose: This research study is looking at blood samples from newborns with Down syndrome. Identifier: NCT00959283
Primary/Site/Co Investigator: Alan C. Homans, MD
Contact: Alan Homans (802) 847-2850
Institution Number: M11-185
Protocol Research Type: Cooperative Group

Last modified December 05 2014 11:48 AM